Displaying items by tag: Department of Medicine

Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
The first target for the UAB spinoff Incysus Ltd. will be glioblastoma. Incysus has just received a European patent for its innovative approach to fighting cancer.
The five-year grant from the NHLBI to the labs of Jennifer and David Pollock also includes a third project at the University of Utah, bringing together three highly successful research entities.
Knowledge from this study and others may help physicians boost healing and prevent heart failure in patients after a heart attack.
The UAB Health Disparities Research Symposium highlights the health disparities work of undergraduate, graduate, faculty and community investigators in basic science, clinical research, behavioral and social science, and community-based research.
As lung diseases worsen worldwide, UAB has launched a pre-doctoral training program in pulmonary research that will focus on lung diseases such as asthma, cancer, COPD, cystic fibrosis, pneumonia, lung injury and idiopathic pulmonary fibrosis.
These leaders represent the next generation of cardiologists who are working to educate their colleagues, conduct research on new and novel strategies to advance cardiovascular care, and innovate the unique aspects of the cardiology specialty. 
The grant will initially fund two fellowship positions for postdoctoral fellows (basic or clinical) wishing to train in the area of heart failure research.
Page 21 of 51